RxDoctor Payments DataLook up a doctor →

Macarena de la Fuente, MD

Neurology · Miami, FLNPI 1952686388

Payments from drug & device makers

$4,871,948in general payments, 2019–2025

Across 595 payments — averaging $8188.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Servier Bioinnovation$3.4M
  • Merck$940K
  • E.r. Squibb & Sons, L.L.C.$243K
  • Agios Pharmaceuticals, Inc.$142K
  • Servier Pharmaceuticals LLC$86K
  • Caris MPI, Inc.$84K
  • plus $23K from 4 others
$7,584in research payments, 2019–2025

Across 15 payments — averaging $505.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Servier Affaires Medicales$5K
  • Servier Bioinnovation$3K

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,871,948 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida

Medicare billing

Part B allowed, 2024
$24,323
Medicare patients
51
Services billed
178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →